209
Views
0
CrossRef citations to date
0
Altmetric
Articles

Synthesis and Properties of New Imidazole Derivatives Including Various Chromophore for OLEDs

, , , , &
 

Abstract

Two new blue compounds were successfully synthesized by introducing phenanthroimidazole group as a side group into pyrene, a chromophore with good luminous efficiency: 1-(4-(10-(naphthalen-2-yl)anthracen-9-yl)phenyl)-2-(pyren-1-yl)-1H-phenanthro[9,10-d]imidazole (NA-PPI) and 1-(4'-(9H-carbazol-9-yl)-[1,1'-biphenyl]-4-yl)-2-(pyren-1-yl)-1H-phenanthro[9,10-d]imidazole (CP-PPI). The optical and electroluminescence properties of newly synthesized materials were measured. Both materials emit blue or sky-blue photoluminescence in the film state and have a high PLQY value of over 80% in solution state. The synthesized materials were applied as EML in non-doped devices, and high efficiency of 3.51 cd/A and EQE of 2.39% in CP-PPI device were achieved.

Acknowledgment

This research was supported by National R&D Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science & ICT (No. 2017M3A7B4041699), the Fundamental R&D Program for Core Technology of Materials funded by the Ministry of Trade, Industry and Energy, Republic of Korea (Project No. 10080565) and Basic Science Research Program through the National Research Foundation of Korea(NRF) funded by the Ministry of Education (No. 2017R1D1A1A09082138).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.